Published in Lab Business Week, November 21st, 2004
"Tissue microarrays are a recent innovation in the field of pathology. They were originally designed as a high-throughput approach for researchers to assess the expression of interesting candidate disease-related genes or gene products simultaneously on hundreds of tissue samples," pathologists in Australia explained.
"However, their use is becoming more widespread in routine pathology, for example for quality assurance and for the optimization of diagnostic reagents such as monoclonal antibodies and gene probes," noted B. Kumar and colleagues at the Victorian Breast Cancer Research...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.